Academic literature on the topic 'Cervix uteri Cancer Victoria Prevention'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Contents
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cervix uteri Cancer Victoria Prevention.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Cervix uteri Cancer Victoria Prevention"
1
Vasilj, Ivan, Semra Cavaljuga, Marija Strnad, and Ariana Znaor. "Endometrial cancer epidemiology and prevention in Federation of Bosnia and Herzegovina, B&H." Bosnian Journal of Basic Medical Sciences 4, no. 4 (November 20, 2004): 63–65. http://dx.doi.org/10.17305/bjbms.2004.3364.
Full textAbstract:
In Federation of Bosnia and Herzegovina during 2002 a total of 67 cases of endometrial cancer (ICD 10th Revision Code C54) were registered among female population older then 15 years (1 per 10,000 population). Nine women were diagnosed with non specific malignant uteri neoplasia (C55)--without clarifying if that was cervix or corpus uteri located cancer, but assumption is that these cancers are actually endometrial cancer. Majority of cases are older then 50 years, 48 of them (71.6%), while 29 (28.4%) are from 15 to 49 years old. During 2000 about 189,000 new endometrial cancer cases were reported with 44,700 endometrial cancer deaths in the World. In this paper we presented geographical distribution of cases registered in FB&H, as well as leading risk factors, protective factors and prevention and possibilities for screening methods.
2
Mathur, Prashant, Krishnan Sathishkumar, Meesha Chaturvedi, Priyanka Das, Kondalli Lakshminarayana Sudarshan, Stephen Santhappan, Vinodh Nallasamy, Anish John, Sandeep Narasimhan, and Francis Selvaraj Roselind. "Cancer Statistics, 2020: Report From National Cancer Registry Programme, India." JCO Global Oncology, no. 6 (September 2020): 1063–75. http://dx.doi.org/10.1200/go.20.00122.
Full textAbstract:
PURPOSE The systematic collection of data on cancer is being performed by various population-based cancer registries (PBCRs) and hospital-based cancer registries (HBCRs) across India under the National Cancer Registry Programme–National Centre for Disease Informatics and Research of Indian Council of Medical Research since 1982. METHODS This study examined the cancer incidence, patterns, trends, projections, and mortality from 28 PBCRs and also the stage at presentation and type of treatment of patients with cancer from 58 HBCRs (N = 667,666) from the pooled analysis for the composite period 2012-2016. Time trends in cancer incidence rate were generated as annual percent change from 16 PBCRs (those with a minimum of 10 years of continuous good data available) using Joinpoint regression. RESULTS Aizawl district (269.4) and Papumpare district (219.8) had the highest age-adjusted incidence rates among males and females, respectively. The projected number of patients with cancer in India is 1,392,179 for the year 2020, and the common 5 leading sites are breast, lung, mouth, cervix uteri, and tongue. Trends in cancer incidence rate showed an increase in all sites of cancer in both sexes and were high in Kamrup urban (annual percent change, 3.8%; P < .05). The majority of the patients with cancer were diagnosed at the locally advanced stage for breast (57.0%), cervix uteri (60.0%), head and neck (66.6%), and stomach (50.8%) cancer, whereas in lung cancer, distant metastasis was predominant among males (44.0%) and females (47.6%). CONCLUSION This study provides a framework for assessing the status and trends of cancer in India. It shall guide appropriate support for action to strengthen efforts to improve cancer prevention and control to achieve the national noncommunicable disease targets and the sustainable development goals.
3
Zulfa, Lathifah Dzakiyyah, Dessyani Salim, and Abigail Tirza Silalahi. "Role of Tomato (Solanum lycopersicum) in Management and Prevention of Four Most Common Cancer in Indonesia." SCRIPTA SCORE Scientific Medical Journal 3, no. 2 (February 28, 2022): 186–91. http://dx.doi.org/10.32734/scripta.v3i2.5522.
Full textAbstract:
Introduction: The rate of new cancer cases in Indonesia is very high. With various risk factors, cancer becomes easier to attack individuals, but that does not mean these factors cannot be changed. One of the modifiable risk factors of cancer is diet from food. Objective: This review aims to investigate the role of chemical compound in tomato (S. lycopersicum) in management and prevention of breast, cervix uteri, lung, and liver cancer. Method: Method for writing this review is by searching for literature published in 2012 - 2020 was carried out to prove the effect of tomatoes on cancer incidence through in vitro, in vivo, and clinical studies. Results: Lycopene in tomatoes has been shown to withstand the cell cycle, inhibit NF-кB, and affect enzymes that produce toxic metabolites, thus preventing the development of various types of cancer. Other active compound such as carotenoid lutein can act as cytotoxic agents by increasing p53 phosphorylation and suppressing the expression of anti-apoptotic genes in breast cancer cells. Interaction between tomatine or tomatidine (another compound in tomatoes) with EGFR will prevent the development or metastasis of non-small cell lung carcinoma. Conclusion: These facts can be concluded that tomato (with various active compound in it) consumption potentially strong in preventing breast, cervix uteri, lung, and liver cancer. Further research should clarify the recommended tomato active compound level for daily consumption and its long-term side effect. Keywords: cancer, diet, Solanum lycopersicum Pendahuluan: Tingkat kasus baru kanker di Indonesia sangatlah tinggi. Terdapat 65.858 kasus baru kanker payudara pada 2020. Dengan berbagai macam faktor risiko, kanker menjadi lebih mudah menyerang individu, namun bukan berarti faktor tersebut tidak dapat diubah. Salah satu faktor risiko yang dapat dimodifikasi adalah diet. Tujuan: Ulasan ini bertujuan untuk membahas bagaimana konsumsi tomat dapat mengurangi risiko terkena kanker maupun memperbaiki prognosis penderita kanker. Metode: Metode penulisan ulasan ini adalah mencari literatur yang dipublikasi selama 2016 – 2021 secara daring dilakukan untuk membuktikan pengaruh tomat terhadap kejadian kanker baik secara in vivo, in vitro, serta penelitian klinis. Hasil: Lycopene yang terkandung pada tomat terbukti menahan siklus sel, menginhibisi NF- B, dan menekan efek enzim yang memproduksi metabolit beracun sehingga bermanfaat dalam mencegah perkembangan berbagai jenis kanker. Bahan aktif lain seperti karotenoid lutein mampu bertindak sebagai agen sitotoksik yang meningkatkan fosforilasi p53 dan menekan ekspresi gen anti – apoptotic pada sel kanker payudara. Interaksi tomatine dan tomatidine (kandungan lain pada tomat) dengan EGFR akan mencegah perkembangan maupun metastasis non-small cell lung carcinoma. Kesimpulan: Beberapa fakta tersebut dapat disimpulkan bahwa konsumsi tomat berpotensi mencegah kanker payudara, serviks uteri, paru – paru, dan hepar. Penelitian selanjutnya perlu membuktikan berapa rekomendasi banyaknya konsumsi tomat harian. Kata Kunci: diet, kanker, tomat
4
Moreira, Rita De Cássia Rocha, Ludmilla Oliveira Souza, Manoela De Assis Silva Carvalho, and Scheila Conceição Sacramento Saldanha. "Perfil epidemiológico do câncer de colo uterino no município de feira de santana, Bahia, Brasil." Revista de Enfermagem UFPE on line 3, no. 4 (September 19, 2009): 998. http://dx.doi.org/10.5205/reuol.581-3802-1-rv.0304200926.
Full textAbstract:
Objective: to determine the cervical cancer epidemiological profile in Feira de Santana city, from 2000 to 2004. Methods: documental research, quantitative methods, descriptive, whose data collection were in annual reports issued by the Municipal Secretariat of Health through the Information System in Cancer of the Uterine Cervix (SISCOLO). The collection instrument was a form consolidated. Descriptive analysis was conducted using statistical tests, calculating the incidence, relative frequency and mortality rates by age. The results are presented in tables. Results: regards to Cervical Intra-epithelial Neoplasia I (CIN I) the age group between 20-39 years old had the greatest number of cases, but in relation to CIN II the age group between 20-39 years old not presented cases in 2004. In CIN III there was an increase in the percentage distribution in the age group between 20-39 years old, there was a decrease in women between 40-59 years old and over 60 years old there were cases only occurred in 2002. The hospital morbidity predominated in the age group between 40-59 years. The absolute frequency shows decrease in the number of cases of hospitalization. Deaths by cervical cancer were predominant in the age group over 60 years old. Conclusion: to know cervical cancer epidemiological variables is fundamental because it makes possible to draw actions which contribute to the women’s health promotion. Descriptors: cancer; cervix uteri; prevention; epidemiology.
5
Momenimovahed, Zohre, and Hamid Salehiniya. "Incidence, mortality and risk factors of cervical cancer in the world." Biomedical Research and Therapy 4, no. 12 (December 8, 2017): 1795. http://dx.doi.org/10.15419/bmrat.v4i12.386.
Full textAbstract:
Background: Cervical cancer imposes a huge global burden. To date, various studies have been conducted on the risk factors associated with cervical cancer. The aim of this study was to investigate the incidence, mortality, and geographical distribution of cervical cancer and its risk factors in the world.
Methods: A literature search was conducted using PubMed, Web of sciences, Scopus, and Google Scholar to search for studies published between 2000 and 2017. The keywords used included cervical cancer, cervix uteri cancer, risk factor, incidence, mortality, and a combination of these terms.
Results: The results of this study showed that the incidence of cervical cancer varies considerably between developed and developing countries. The findings of this study demonstrated that several factors including sexually transmitted infections, reproductive factors, hormonal influences, genetics and host factors are responsible for the incidence of cervical cancer.
Conclusion: The results of this review study suggested that combination of biological, economic and health factors contributes to the incidence of cervical cancer. A large proportion cervical cancer can be prevented by prevention programs, lifestyle enhancement, smoking cessation, and timely and effective treatment of pre-cancerous lesions.
6
Rees, Margaret, Roberto Angioli, Robert L. Coleman, Rosalind M. Glasspool, Francesco Plotti, Tommaso Simoncini, and Corrado Terranova. "European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis." International Journal of Gynecologic Cancer 30, no. 4 (February 11, 2020): 428–33. http://dx.doi.org/10.1136/ijgc-2020-001217.
Full textAbstract:
Worldwide, it is estimated that about 1.3 million new gynecological cancer cases are diagnosed each year. For 2018, the predicted annual totals were cervix uteri 569 847, corpus uteri 382 069, ovary 295 414, vulva 44 235, and vagina 17 600. Treatments include hysterectomy with or without bilateral salpingo-oophorectomy, radiotherapy, and chemotherapy. These can result in loss of ovarian function and, in women under the age of 45 years, early menopause. The aim of this position statement is to set out an individualized approach to the management, with or without menopausal hormone therapy, of menopausal symptoms and the prevention and treatment of osteoporosis in women with gynecological cancer. Our methods comprised a literature review and consensus of expert opinion. The limited data suggest that women with low-grade, early-stage endometrial cancer may consider systemic or topical estrogens. However, menopausal hormone therapy may stimulate tumor growth in patients with more advanced disease, and non-hormonal approaches are recommended. Uterine sarcomas may be hormone dependent, and therefore estrogen and progesterone receptor testing should be undertaken to guide decisions as to whether menopausal hormone therapy or non-hormonal strategies should be used. The limited evidence available suggests that menopausal hormone therapy, either systemic or topical, does not appear to be associated with harm and does not decrease overall or disease-free survival in women with non-serous epithelial ovarian cancer and germ cell tumors. Caution is required with both systemic and topical menopausal hormone therapy in women with serous and granulosa cell tumors because of their hormone dependence, and non-hormonal options are recommended as initial therapy. There is no evidence to contraindicate the use of systemic or topical menopausal hormone therapy by women with cervical, vaginal, or vulvar cancer, as these tumors are not considered to be hormone dependent.
7
Kim, Jinhee, Donghwan Lee, Kyung-Bok Son, and SeungJin Bae. "The Burden of Cervical Cancer in Korea: A Population-Based Study." International Journal of Environmental Research and Public Health 17, no. 17 (August 30, 2020): 6308. http://dx.doi.org/10.3390/ijerph17176308.
Full textAbstract:
This study used the Korean National Health Insurance (NHI) claims database from 2011 to 2017 to estimate the incidence and the incidence-based cost of cervical cancer and carcinoma in situ of cervix uteri (CIS) in Korea. The primary outcome was the direct medical cost per patient not diagnosed with cervical cancer (C53) or CIS (D06) 2 years prior to the index date in the first year after diagnosis. A regression analysis was conducted to adjust for relevant covariates. The incidence of cervical cancer tended to decrease from 2013 to 2016, while that of CIS increased. In particular, the incidence rate of CIS in women in their 20 s and 30 s increased by 56.8% and 28.4%, respectively, from 2013 to 2016. The incidence-based cost of cervical cancer and CIS was USD 13,058 and USD 2695 in 2016, respectively, which increased from 2013. Multivariate regression analysis suggested that age was the most influential variable of the cost in both patient groups, and the cost was highest in those aged over 60, i.e., the medical cost was significantly lower in younger women than their older counterparts. These findings suggest that targeting younger women in cervical cancer prevention is a reasonable option from both economic and public health perspectives.
8
Demissie, Birhanu Wondimeneh, Gedion Asnake Azeze, Netsanet Abera Asseffa, Eyasu Alem Lake, Befekadu Bekele Besha, Kelemu Abebe Gelaw, Taklu Marama Mokonnon, Natnael Atnafu Gebeyehu, and Mohammed Suleiman Obsa. "Communities’ perceptions towards cervical cancer and its screening in Wolaita zone, southern Ethiopia: A qualitative study." PLOS ONE 17, no. 1 (January 7, 2022): e0262142. http://dx.doi.org/10.1371/journal.pone.0262142.
Full textAbstract:
Background Cervical cancer is a malignant neoplasm from cells originating in the cervix uteri. Any woman who is sexually active is at risk of getting HPV. Women in sub-Saharan Africa region have higher chance of developing the disease. There are nearly 26 million Ethiopian women who are over the age of 15 and believed to be at risk of getting HPV. Regrettably, Ethiopian women typically present for cervical cancer care at a late stage in the disease, where treatment is most ineffective. Objectives To explore communities’ perceptions of cervical cancer and screening among women in Wolaita zone, southern Ethiopia. Methods A qualitative research using focused group discussions and in-depth interviews was used to explore communities’ perceptions of cervical cancer and screening among women in Wolaita zone, southern Ethiopia from March 2018-November 2019. The study participants were men, women and communities who were residents of the study settings and were not health professionals. All focused group discussions (FGDs) and key informant interviews were transcribed and entered into Microsoft Word and thematic content analysis was done. Results A total of fifty-nine participants participated in both FGD (three with men and six with women) and in-depth interviews (IDIs). Most participants have not heard about cervical cancer but know cancer in general. Participants mentioned that the disease usually relates to many births and unprotected sexual intercourse but none mentioned HPV infection. Most of the participants perceive that cervical cancer is incurable and assume that it could be prevented but they think they are not vulnerable to the disease and screening is not necessary. Conclusion This study indicates that rural communities in the zone had limited knowledge about cervical cancer and even less about risk factors, screening, treatment and prevention. There is a great need for cancer education and prevention in Ethiopia.
9
Badar, F., and N. Anwar. "SP3-28 Is vaccination against the human papillomavirus for prevention of the cervix uteri cancer indicated in Pakistan where there is no Pap smear cervical cancer screening program-a public health perspective?" Journal of Epidemiology & Community Health 65, Suppl 1 (August 1, 2011): A416. http://dx.doi.org/10.1136/jech.2011.142976o.28.
Full text
10
Hussain, Syed Md Akram. "Comprehensive update on cancer scenario of Bangladesh." South Asian Journal of Cancer 02, no. 04 (October 2013): 279–84. http://dx.doi.org/10.4103/2278-330x.119901.
Full textAbstract:
AbstractBangladesh, at 142 million people, is the ninth most populous country in the world. There are 13 to 15 lakh cancer patients in Bangladesh, with about two lakh patients newly diagnosed with cancer each year. As an overview, lung cancer and mouth-oropharynx cancer rank as the top two prevalent cancers in males. Other types of cancers are esophagus cancer and stomach cancer. In women, cancer cervix uteri and breast cancer are most prevalent. Other cancer types, which affect women, are mouth and oropharynx cancer, lung cancer, and esophagus cancer. There are around 150 qualified clinical oncologists and 16 pediatric oncologists working in the different parts of the country. Regular cancer treatment is available in 19 hospitals and 465 hospital beds are attached as indoor or day care facilities for chemotherapy in the oncology/radiotherapy departments. There are about 15 linear accelerators, 12 Co-60 teletherapy and 12 brachytherapy units currently available. Approximately, 56 cancer chemotherapeutic agents are obtainable in Bangladesh. Research facilities are available at tertiary care centers and a few multi country collaborative research activities are ongoing. Bangladesh has a unique National Cancer Control Strategy and Plan of Action 2009-2015 formulated with the assistance of WHO with an objective to develop and implement continuum of cancer care through a comprehensive cancer control programe. Preventive measures taken to reduce the incidence of cancer include reduced tobacco smoking, change of dietary habit and reduced food adulteration, ensuring reproductive hygiene, increased physical activity, and reduced occupational hazard. Awareness buildup and media campaign are going on by organizing the general people, opinion leaders of the society, and boy and girl scout. Training of general physicians on cancer warning signs and setup of early cancer detection centers at each medical college and district levels are ongoing. Beside these, some other major cancer programs have taken place for early detection of breast, cervical and oral cancer by Bangladesh Government and NGOs such as ICDDR'B, BRAC, Ahsania Mission Cancer Hospital, BSMMU, Bangladesh Cancer Society, Ashic Foundation, Amader Gram, AK Khan Healthcare Trust, CANSUP, Oncology club etc. Piloting of cervical cancer vaccination has recently been completed. Improving the cancer scenario overnight is not an easy task but policy makers may become interested and push this agenda forward, if the huge health impact and economic loss caused by cancer become evident to them. Besides, Bangladesh has accepted reduction of cancer morbidity and mortality targets set by United Nations and World Health Organization as a part of global non-communicable disease prevention agreement.
Dissertations / Theses on the topic "Cervix uteri Cancer Victoria Prevention"
1
張雨萍 and Yu-ping Cheung. "Overview of cost-effectiveness of cervical cancer screening: a systematic review." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2008. http://hub.hku.hk/bib/B4170969X.
Full text
2
Choi, Cheuk-wai, and 蔡卓偉. "Modeling the potential impact of HPV vaccination on Hong Kong's cervical cancer burden." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2014. http://hdl.handle.net/10722/206747.
Full textAbstract:
Background. Cervical cancer is a common female cancer in Hong Kong. Cervical screening has been used in detecting cervical lesions for several decades. Given that human papillomavirus (HPV) infection is the etiological cause of cervical cancer, highly efficacious HPV vaccines are recently developed for preventing against HPV infection. Hong Kong has a well-developed healthcare system but relatively high cervical cancer incidence compared to other developed countries partly due to its suboptimal cervical screening program. This highlights the significance to evaluate the potential of implementing organized HPV vaccination programs for further reducing cervical cancer burden on top of cervical screening in Hong Kong.
Methods. Cross-sectional, population-based surveys were conducted to assess the acceptability of female adolescent HPV vaccination among girls from secondary schools in 2008 and among mothers of adolescent daughters in 2008 and 2012. Mathematical model with transmission dynamic and stochastic individual-based components was constructed to model the natural history of HPV infection and cervical cancer and thus to project the public health and economic impacts of organized female adolescent HPV vaccination programs in a societal perspective. The model used Markov Chain Monte Carlo algorithm to estimate natural history parameters of HPV infection and probabilistic sensitivity analysis to consider the uncertainty of costs and health utilities in the economic evaluation of organized HPV vaccination.
Results. Reported vaccine uptake among11–18 year-old girls increased from 2.4% among schoolgirls in 2008 to 9.1% among daughters of interviewed mothers in 2012. Among interviewed mothers, 27.5% and 37.6% of them were willing to have their daughters vaccinated at market price in 2008 and 2012, respectively. The mathematical model projected that HPV prevalence decreased soon after mass HPV vaccination and vaccine-induced cervical cancer reduction became obvious after vaccination programs have been launched for 30 years. If HPV vaccinesprovided30-year protection, the median incremental cost-effectiveness ratio (ICER) of routine HPV vaccination programs for 12 year-old girls at 25–75% vaccination coverage was US$26,367–32,527 per quality-adjusted life-year (QALY). The median ICER was above US$48,000/QALY if adding 2-year catch-up program for13–18 year-old girls and above US$58,000/QALY if vaccines protect against HPV infection for only 15 years.
Conclusions. This study presented the first evaluation of organized HPV vaccination programs in Hong Kong. If vaccine protection lasted for 30 years or longer, organized routine HPV vaccination for 12 year-old girls would potentially be a cost-effective add-on in substantially reducing cervical cancers and HPV-related diseases on top of cervical screening in Hong Kong at an ICER threshold of US$33,218/QALY. However, the current estimated vaccine uptake was unexpectedly low and vaccine acceptability was only moderate. The findings indicated the importance to devise efficient strategies in achieving high and universal coverage for maximizing the population-level benefits of HPV vaccination. Policymakers should consider integrating the organized HPV vaccination programs with existing infrastructures to promote higher acceptability, to translate willingness to vaccinate to actual uptake, to assess population effectiveness, and to monitor safety issue and potential replacement effect of non-vaccine targeted HPV types following mass vaccination.published_or_final_version
Public Health
Doctoral
Doctor of Philosophy
3
Fallala, Muriel Selma. "Cervical cancer screening : safety, acceptability, and feasibility of a single-visit approach in Bulawayo, Zimbabwe." Thesis, Stellenbosch : Stellenbosch University, 2014. http://hdl.handle.net/10019.1/97187.
Full textAbstract:
Thesis (MFamMed)--Stellenbosch University, 2014.OBJECTIVE: The purpose of the study was to assess the safety, acceptability and feasibility of Visual Inspection with Acetic Acid and Cervicography (VIAC) followed by Cryotherapy or Loop Electrical Excision Procedure (LEEP) at a single visit for prevention of cancer of the cervix in Bulawayo, Zimbabwe. STUDY DESIGN: The study was descriptive using retrospective data extracted from electronic medical records of women attending the VIAC clinic at United Bulawayo Hospital in the period 1st February2010 to 31st December2012.Over 24 months 4641 women visited the clinic and were screened for cervical cancer using VIAC. If positive and eligible, cryotherapy or LEEP was offered immediately. Treated women were followed up at 3months and 1 year. RESULTS: The VIAC test positive rate was 10.8%.Of those eligible,17.0% received immediate cryotherapy, 44.1%received immediate LEEP, 1.9% delayed treatment and 37.0% were referred to a gynaecologist. No major complications were recorded after cryotherapy or LEEP. Among those treated99.5% expressed satisfaction with their experience. Only 3.2% of those treated at the clinic were VIAC positive one year later. The service was shown to be feasible to sustain over time with the necessary consumables. There were no service-related treatment postponements and the clinic staff and facility were able to meet the demand for the service. CONCLUSION: A single visit approach using VIAC, followed by cryotherapy or LEEP proved to be safe, acceptable and feasible in an urban African setting in Bulawayo, Zimbabwe.
AFRIKAANSE OPSOMMING: Geen opsomming beskikbaar.
4
許素安 and So-on Hui. "An education intervention to improve cervical smear screening attendance rate among Hong Kong women." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2008. http://hub.hku.hk/bib/B40720731.
Full text
5
Zhao, Yingzi, and 赵缨姿. "Immunogenicity and safety of two human papillomavirus vaccines for cervical cancer among Asian female populations : a systematic review." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hdl.handle.net/10722/193778.
Full textAbstract:
Cervical cancer is one of the common cancers among women and poses a great burden to the public health. Currently there are two human papillomavirus vaccines, CervarixTM and Gardasil®, against HPV type 16/18 and type 6/11/16/18 cervical cancer available in the market. Most clinical trials about immunogenicity and safety of the two vaccines were conducted among Caucasian females, rather than on Asian female populations. This systematic review aims to summarize and evaluate immunogenicity and safety of the two vaccines conducted mainly at the setting of randomized control trials on Asian female populations. This investigation would enhance understanding about whether ethnic difference impacts antibody responses, what were the severe adverse events in Asian populations, and whether the vaccines demonstrate satisfactory immunogenicity.
Eleven relevant studies were identified from Pubmed and Medline with totally 4026 subjects involved. The quality and validity of these studies was critically appraised in terms of randomization, allocation ratio, blinding, analytical methods and other potential limitations.
The two vaccines demonstrated high geometric mean antibody titer levels among Asian females. Injection-site pain was the mostly complained solicited local symptom, followed by redness and swelling. Few severe solicited local symptoms were reported. The unsolicited symptoms were not as common as solicited symptoms and quite a few of them were not related to the vaccination. One severe adverse event was confirmed in Japan’s study – a spontaneous abortion had taken place 15 days after vaccination.
China lacks of systematic cancer registries, therefore it is difficult to estimate the disease burden. China’s Gross Domestic Product only reached $5445 per capita in 2011. HPV vaccination would not be cost-effective in the countries which had Gross Domestic Product lower than $8505 per capita, therefore piloting the HPV vaccination in major economic powerhouses like Shanghai and Beijing would be more realistic.
To sum up, this systematic review demonstrated satisfactory immunogenicity on Asian females. The safety data were acceptable to some extent except one spontaneous abortion occurred in Japan’s study.published_or_final_version
Public Health
Master
Master of Public Health
6
Wong, Chi-kuan Ada, and 黃智君. "Knowledge and perception on cervical cancer screening and prevention among nursing graduates in Hong Kong." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2011. http://hub.hku.hk/bib/B46942956.
Full text
7
Beaumont, Nerida. "The relative importance of barriers to cervical cancer screening in older women : A review of 140 women and their pap smear providers." Thesis, Edith Cowan University, Research Online, Perth, Western Australia, 1999. https://ro.ecu.edu.au/theses/1218.
Full textAbstract:
Cervical cancer remains a significant cause of death in women. There is a notable age related decrease in levels of screening and women aged over 50 years with later, more invasive disease. One hundred and forty women aged between 50 and 69 years (M "'58.21 years) and 23 Pap smear providers completed a Cervical Cancer Screening Questionnaire designed to identify the relative importance of barriers to attendance for cervical screening, as well as providers own barriers and issues. Responsibility for health, familiarity with, and ratings of the usefulness of Pap smears were the major dimensions along which regular and non-regular attenders differed supporting the hypothesis. Additionally, women who had regular Pap smears were younger, with higher levels of confidence in their provider, in the ability of the test to detect cervical cancer and in their overall value for the usefulness of the test. The application of the findings of the present study may improve the currently inconsistent promotion of cervical screening to older women. The use of a theoretical framework informed by the Theory of Reasoned Action and Multi-Attribute Utility Theory showed promising results in incorporating the diverse factors involved in participating. in preventative health screening. Recommendations are made on the necessity of both targeted and general intervention strategies to increase the uptake of preventative screening by at-risk groups.
8
Ko, Woon Yee Jessie. "A source-based inquiry of optimistic bias and its impact on health-related behaviors : implications for cervical cancer prevention communications." HKBU Institutional Repository, 2011. http://repository.hkbu.edu.hk/etd_ra/1283.
Full text
9
Jensen-Ross, Christine, and University of Lethbridge School of Health Sciences. "Cervical screening among Southern Alberta First Nations women living off-reserve." Thesis, Lethbridge, Alta. : University of Lethbridge, School of Health Sciences, 2006, 2006. http://hdl.handle.net/10133/400.
Full textAbstract:
First Nations women face nearly three times the risk of cervical cancer and
mortality rates of up to six times higher than their non-Aboriginal counterparts. While
cervical cancer is almost completely preventable, Southern Alberta First Nations women seldom access cervical screening services. The purpose of this qualitative focused
ethnography was to gain an understanding of the cervical screening needs of un- and
under-served First Nations women living off-reserve. Thirteen purposefully selected First Nations women participated in three focus groups utilizing semi-structured interviews. Personal self-worth and cervical screening awareness and relevance are essential
to the pursuit of cervical screening. Barriers and incentives for screening and
opportunities for acceptability and sustainability are explored. A holistic approach, intersectoral collaboration and cultural safety are described by focus group participants as foundational for optimal service delivery.xii, 223 leaves ; 29 cm.
10
Vale, Diama Bhadra Andrade Peixoto do 1978. "Avaliação do rastreamento do câncer do colo do útero na estratégia de saúde da família no município de Amparo, São Paulo, Brasil." [s.n.], 2010. http://repositorio.unicamp.br/jspui/handle/REPOSIP/310559.
Full textAbstract:
Orientador: Luiz Carlos ZeferinoDissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas
Made available in DSpace on 2018-08-16T19:33:51Z (GMT). No. of bitstreams: 1 Vale_DiamaBhadraAndradePeixotodo_M.pdf: 6577919 bytes, checksum: 70e533105be682a7083418f3bad0b3a0 (MD5) Previous issue date: 2010
Resumo: O rastreamento do câncer do colo do útero no Brasil não tem sido efetivo em reduzir as altas taxas de incidência e mortalidade desta neoplasia, apesar de o Ministério da Saúde ter estabelecido há mais de 20 anos as normas definindo a população-alvo e a periodicidade dos controles. A territorialização e o cadastramento das famílias pelo Programa de Saúde da Família favorecem a ruptura com o padrão oportunístico do rastreamento e com a identificação das mulheres que nunca fizeram o exame citológico ou estão há mais de três anos sem fazê-lo. Este estudo analisou se o rastreamento do câncer do colo do útero avançou no sentido de seguir as recomendações vigentes, ao longo de sete anos de implantação do Programa de Saúde da Família em Amparo, município do interior de São Paulo, referência em ações de atenção básica. Os objetivos foram verificar a variação da frequência dos exames realizados em função do intervalo desde o último controle, do grupo etário, da cobertura das ações de rastreamento e dos exames realizados em excesso. O estudo foi longitudinal e retrospectivo. Os sujeitos foram todas as mulheres usuárias do Sistema Único de Saúde que realizaram o exame citológico de rastreamento de janeiro de 2001 a dezembro de 2007. Para análise estatística, foi utilizado o teste de qui-quadrado modificado por Cochran-Armitage para tendência. A periodicidade anual manteve-se alta no período do estudo, variando entre 51,2% e 59,7% do total dos controles realizados. Houve aumento estatisticamente significante, ainda que discreto, em números relativos, dos exames realizados com intervalo de dois anos ou mais desde o último controle, como também houve redução das mulheres realizando exame pela primeira vez. A distribuição de exames tendeu a aumentar no grupo etário 40-59 anos e a diminuir no grupo etário com mais de 60 anos. Os percentuais de exames em excesso variaram de 61,2% a 65,5%. Concluindo, a qualificação do rastreamento do câncer do colo do útero foi discreta e não modificou o padrão oportunístico dos controles. O Programa da Saúde da Família, ainda que possa ser uma estratégia com potencial para organizar o rastreamento do câncer do colo do útero no Brasil, não mostrou impactos evidentes neste sentido. Os agentes comunitários de saúde, componentes das equipes de saúde da família, podem atuar no sentido de identificar as mulheres-alvo que não estão realizando regularmente os controles periódicos. Portanto é essencial capacitá-los para cumprir este papel
Abstract: Cervical cancer screening in Brazil has failed to reduce the high incidence and mortality rates associated with this disease despite the fact that the Brazilian Ministry of Health established regulations defining the target population and the periodicity of screening tests over 20 years ago. The territorial distribution and the registration of families in the Family Health Program should interrupt the opportunistic screening pattern, identifying women who have never been screened or who were last screened over three years previously. This study evaluated whether any progress had been achieved in cervical cancer screening in terms of compliance with the current recommendations over the period of seven years since implementation of the Family Health Program in Amparo, a township in the state of São Paulo and a reference in primary healthcare. The objectives of this longitudinal, retrospective study were to analyze the variation in the frequency of testing in accordance with the interval since previous screening, age group, the coverage provided by the screening actions and the extent of unwarranted testing. The subjects consisted of all the women using the Brazilian National Health Service who had been submitted to a cervical smear test between January 2001 and December 2007. The Cochran-Armitage test for trend was used in the statistical analysis. Annual periodicity remained high throughout the observation time of the study, ranging from 51.2% to 59.7% of the total number of screening tests performed. There was a statistically significant increase in the tests performed within an interval of two years or more since the previous screening; however, this increase was modest in relative numbers. In addition, a reduction was found in the number of women undergoing testing for the first time. The distribution of tests according to age group showed a tendency towards an increase in the 40-59 year age group and a decrease in the over-60s age group. The percentage of unwarranted tests ranged from 61.2% to 65.5%. In conclusion, the improvement in cervical cancer screening was slight and was insufficient to alter the opportunistic pattern of screening. Although Brazil?s Family Health Program has the potential to organize cervical cancer screening in the country, there is no evidence of any significant change at this moment. The community healthcare agents working in the Family Health Program teams could implement measures for identifying target women who are not being submitted to regular screening; hence they should be trained to perform this role
Mestrado
Oncologia Ginecológica e Mamária
Mestre em Ciências da Saúde
Books on the topic "Cervix uteri Cancer Victoria Prevention"
1
Preventing cervical cancer: What every woman should know. St. Albans, Herts, England: Altman, 2007.
Find full text
2
Gebbie, Kristine M. Washington cancer control plan: Smoking-related, breast, and cervical cancer. Olympia, Wash: Washington State Dept. of Health, Office of Heart Disease and Cancer Prevention, 1991.
Find full text
3
Pennsylvania. General Assembly. Joint State Government Commission. Cervical cancer in Pennsylvania: Easing the burden. Harrisburg, Pa: Joint State Government Commission, 2004.
Find full text
4
Gong jing ai fang zhi zhi nan: Gongjing ai fangzhi zhinan. Wuhan Shi: Hubei ke xue ji shu chu ban she, 2015.
Find full text
5
Ahuja, Maninder. Precancerous lesions of cervix: Prevention, early diagnosis and management. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd, 2014.
Find full text
6
Julian, Chomet, ed. Cervical cancer: All you and your partner need to know about its prevention, detection and treatment. Wellingborough, England: Grapevine, 1989.
Find full text
7
Vaccines for the prevention of cervical cancer. Oxford: Oxford University Press, 2010.
Find full text
8
E, Rohan Thomas, and Shah Keerti V, eds. Cervical cancer: From etiology to prevention. Dordrecht: Kluwer Academic, 2004.
Find full text
9
Vermont. Dept. of Health. Eradication of cervical cancer: Report to the Legislature on Act 110 (2006 ADJ session). Burlington, Vt: Vermont Dept. of Health, 2007.
Find full text
10
Vermont. Dept. of Health. Eradication of cervical cancer: Report to the Legislature on Act 110 (2006 ADJ session). Burlington, Vt: Vermont Dept. of Health, 2007.
Find full text